TABLE 4.

Description of methods for antigen detection of C. pneumoniae in vascular tissue

StudyYrMethod 1Method 2Control method
TechniqueAntibodyaTechniqueAntibodyaTechniqueAntibodya
Shor et al. (128)1992ICCCF-2ICCRR-402ICCKK-12
Kuo et al. (71)1993ICCCF-2ICCRR-402ND
Kuo et al. (72)1993ICCCF-2ICCRR-402ICCKK-12
Kuo et al. (73)1995ICCCF-2ICCTT-401ICCKK-12
Campbell et al. (17)1995ICCCF-2ICCTT-401ND
Grayston et al. (43)1995ICCCF-2ICCTT-401ICCKK-12
Ong et al. (102)1996IFNSbNScND
Muhlestein et al. (94)1996IFBaxterNDND
Ramirez et al. (113)1996ICCNSICCNSND
Juvonen et al. (65)1997ICCLPSICCIHPICCF. tularensis
Juvonen et al. (66)1997ICCLPSICCRR-402ND
Jackson et al. (58)1997ICCCF-2ICCTT-401ND
Jackson et al. (59)1997ICCCF-2NDND
Kuo et al. (74)1997ICCCF-2NDND
Chiu et al. (19)1997ICCChlamydia-Cel-PnICCTT-401ND
Yamashita et al. (151)1998ICCCF-2ICCAY-6ICCVirostat 1641
Shor et al. (129)1998ICCCF-2NDND
Davidson et al. (25)1998ICCCF-2ICCRR-402ND
Ouchi et al. (104)1998ICCCF-3ICCRR-402, AY-6ICCKK-12, Virostat 1651
Ericson et al. (30)2000IFPathfinderICCRR-402ND
  • a C. pneumoniae-specific antibodies: RR-402, TT-401, Chlamydia-Cel-Pn, AY-6; Chlamydia genus-specific antibodies: CF-2, Baxter, LPS, and Pathfinder; C. trachomatis-specific antibodies: KK-12, Virostat 1641, and Virostat 1651.

  • b NS, not stated.

  • c ND, not done.